Osmotica Pharmaceuticals Plc Net Income

Osmotica Pharmaceuticals Plc (OSMT) currently reports a net income of $-68M as of June 2023. That compares with $-57M in the prior-year period — down 20.8% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Osmotica Pharmaceuticals Plc's net income history and peer comparisons.

Osmotica Pharmaceuticals Plc's net income decreased from $-57M to $-68M — a 20.8% year-over-year decrease (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Osmotica Pharmaceuticals Plc's net income of $-68M is lower than the Healthcare sector average of $16B. That is roughly 100.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Osmotica Pharmaceuticals Plc reported $-68M in net income as of June 2023. That compares with $-57M in the prior-year period — down 20.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-68M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Osmotica Pharmaceuticals Plc, and consider following OSMT for alerts when major investors trade the stock.